SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006184
Filing Date
2022-02-14
Accepted
2022-02-14 16:37:47
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 6236
  Complete submission text file 0000899243-22-006184.txt   7717
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Reporting) CIK: 0001494695 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-40629 | Film No.: 22633301

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)